Posts

Global Kinetics’ Personal KinetiGraph Identies Parkinson’s Patients Suitable For Deep Brain Stimulation

/in

Link to Full Article A new study shows the Personal KinetiGraph wearable monitor can help clinicians identify the Parkinson’s disease patients most likely to benet from device-assisted therapies, including deep brain stimulation. Global Kinetics’ Personal KinetiGraph (PKG) wearable sensor system can identify the best candidates for deviceassisted therapies for Parkinson’s disease, including deep brain stimulation, […]

Read more

‘Unique’ rehabilitation exercise trial seeks participants with MS

/in

Link to Full Article People with multiple sclerosis (MS) are being sought to take part in a study that aims to investigate the benefits of a robotic walking device. Karen Saunders, a consultant clinical and research neuro-physiotherapist, is the co-investigator on a feasibility trial that is evaluating the use of a balance exercise programme that […]

Read more

Data Published in Sensors Supports the Use of Global Kinetics’ Personal KinetiGraph® for Objective Assessment of Parkinson’s Disease Patients Who May Benefit From Device-Assisted Therapies

/in

Link to Full Article Novel screening tool provides first objective assessment for managing referral for deviceassisted therapy (DAT), including deep brain stimulation (DBS) and infusion therapies, and has potential to improve management of Parkinson’s Disease PORTSMOUTH, N.H. and LONDON and MELBOURNE, Australia, June 04, 2019 (GLOBE NEWSWIRE) — Global Kinetics Corporation Ltd. today announced the […]

Read more

Global Kinetics Corporation’s PKG® Provides Clinically Meaningful Improvement in Symptom Assessment, Management, Medication Optimization, and PatientClinician Conversations in Parkinson’s Disease

/in

Link to Full Article Data Recently Presented at the 2019 American Academy of Neurology’s Annual Meeting APPRISE Clinical Study Continues Enrollment at 10 Movement Disorder Clinics in the U.S. PORTSMOUTH, N.H. and LONDON and MELBOURNE, Australia, May 07, 2019 (GLOBE NEWSWIRE) — Global Kinetics today reported data that was recently presented at poster presentation sessions […]

Read more

Pilot Project Tests Wrist Device That Monitors Symptoms at Home

/in

Link to full article A pilot project in the United Kingdom is testing a wrist device that is worn like a watch, called Personal Kinetigraph (PKG), to help Parkinson’s patients and their specialist healthcare providers to monitor their condition at home. The PKG, developed  Global Kinetics, will be tested in the “Developing Home-based Parkinson’s Care” project, […]

Read more

Global Kinetics Corporation Appoints Greg Barrett As Independent Director to its Board of Directors

/in

Link to full article PORTSMOUTH, NH USA, and MELBOURNE, Australia, April 2, 2019 Global Kinetics Pty Ltd., a medical device company focused on the development and commercialization of the first FDA-cleared and CE-marked wearable watch for the objective treatment and management of Parkinson’s disease, called the Personal KinetiGraph® (PKG®), today announced the appointment of Gregory […]

Read more

UK Team to Test Robot-assisted Exercise to Improve Balance in MS Patients

/in

Researchers at Kent and Canterbury Hospital, U.K., are recruiting 20 patients with multiple sclerosis (MS) who can walk at least eight meters with a walking aid to test the effectiveness of a five-week exercise program using assistive robotic technology. The Rex device — made  Rex Bionics — is a maneuverable exoskeleton that straps to and supports a […]

Read more

Data Published in the Journal of Parkinson’s Disease Demonstrate Real-World Clinical Benefit of Global Kinetics’ Personal KinetiGraph® in Optimizing Parkinson’s Disease Therapy

/in

– Additional monitoring data helped clinicians optimize drug therapy in nearly onethird of study patients – PORTSMOUTH, NH USA, LONDON, UK, MELBOURNE, Australia, and MOUNTAIN VIEW, CA USA February 4, 2019 – Global Kinetics Corporation Ltd., in conjunction with the Parkinson’s Institute and Clinical Center, today announced the publication of a joint study in the […]

Read more

MS Clinical Trial starting at East Kent

/in

Rex Bionics is the pioneer of the REX® robotic rehabilitation device that provides standing, walking and exercise support for people with lower limb weakness or paralysis; and is used people who have suffered a spinal cord injury, stroke, traumatic brain injury or other neurological condition such as multiple sclerosis. Rex Bionics has worked with physiotherapists […]

Read more

BioWorld Medtech – Canadian med tech, venture capital firm go global with medical implant analytics

/in

January 5, 2019 Excerpted from BioWorld MedTech, Volume 22, No.109, June 6, 2018 By David Godkin, Staff Writer The global orthopedic implants market valued at $47 billion in 2016 is expected to grow to $75 billion 2023. To get a piece of that action, lead investors at Vancouver, B.C.-based Quark Venture Inc. are investing $10 million in Chirp data analytics […]

Read more